Analyst Consensus ?
ConsensusHold26 ratings
Bullish1246.2%
Neutral1142.3%
Bearish311.5%
Palantir Technologies Inc. · PLTR · FY2026 Q1 · Calendar Q2 2026
Palantir Q1 Revenue Jumps 85% YoY as AIP Platform Wins Expand Across Government and Commercial
Palantir delivered accelerating growth in FY2026 Q1, with revenue up 85% year-over-year to $1.63 billion, topping consensus estimates of $1.54 billion by 5.9%. EPS of $0.33 exceeded the $0.28 consensus by 19%. The AIP platform is now the central growth engine, winning contracts across defense (USDA, Maven, Navy Ship OS) and commercial (GE Aerospace, Motor, Freedom Mortgage). Despite the beat, shares fell 7.7% on an abnormal basis in the next session, partially recovering with 4.6% subsequent drift. The stock trades at $131.53 versus a consensus analyst target of $185.36, suggesting meaningful upside remains priced in by the Street even after the post-earnings pullback.
Reported After market closeNASDAQTechnology
$302.00B market cap
100quality score
Company context
Snapshot as of publicationPalantir Technologies Inc. engineers and deploys advanced software platforms primarily for the intelligence community, supporting counterterrorism investigations and operations across the United States, the United Kingdom, and internationally. One such product is Palantir Gotham, a sophisticated software system that enables users to uncover hidden patterns within diverse datasets, from signals intelligence to confidential informant reports. Gotham also facilitates the seamless handover between analysts and operational personnel, helping operators strategize and execute real-world responses to threats pinpointed within the platform.…
Earnings scorecard
Reported versus consensus
Reported EPS
$0.33
Consensus $0
EPS surprise
+19.0%
Reported versus consensus
Reported revenue
$1.63B
Consensus $1.54B
Revenue surprise
+5.9%
Reported versus consensus
Earnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$131.53Previous close
$4.5Low
$124.39Average
$230High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Jul 28, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Citigroup | Buy | Buy | Maintain | Jul 24, 2026 |
| DA Davidson | Buy | Buy | Maintain | Jul 17, 2026 |
| Wolfe Research | Peer Perform | Underperform | Upgrade | Jun 16, 2026 |
| Wedbush | Outperform | Outperform | Maintain | Jun 5, 2026 |
| Rosenblatt | Buy | Buy | Maintain | Jun 5, 2026 |
| Argus Research | Buy | Hold | Upgrade | May 6, 2026 |
| RBC Capital | Underperform | Underperform | Maintain | May 5, 2026 |
| HSBC | Hold | Buy | Downgrade | May 1, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Apr 14, 2026 |
| UBS | Buy | Buy | Maintain | Mar 18, 2026 |
| Freedom Broker | Buy | Sell | Upgrade | Feb 13, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Nov 4, 2025 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Nov 4, 2025 |
| Goldman Sachs | Neutral | Neutral | Maintain | Nov 4, 2025 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | Nov 4, 2025 |
| Baird | Neutral | Neutral | Maintain | Nov 4, 2025 |
| B of A Securities | Buy | Buy | Maintain | Nov 4, 2025 |
| Loop Capital | Buy | Buy | Maintain | Aug 5, 2025 |
| Deutsche Bank | Hold | Sell | Upgrade | Aug 5, 2025 |
| William Blair | Market Perform | Underperform | Upgrade | Mar 5, 2025 |
| Northland Capital Markets | Market Perform | Market Perform | Maintain | Feb 4, 2025 |
| Jefferies | Underperform | Underperform | Maintain | Feb 4, 2025 |
| Benchmark | Buy | Buy | Maintain | Dec 20, 2024 |
| Raymond James | Market Perform | Outperform | Downgrade | Sep 23, 2024 |
| Monness, Crespi, Hardt | Sell | Neutral | Downgrade | Jun 21, 2024 |
| Credit Suisse | Neutral | Neutral | Maintain | May 10, 2023 |
Named analyst price targets
Upside is calculated against the persisted previous close $131.53. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| D.A. Davidson | Analyst unavailable | $175 | $125.73 | +33.0% | Jul 2, 2026 |
| UBS | Karl Keirstead | $200 | $129.98 | +52.1% | Jun 16, 2026 |
| Cantor Fitzgerald | Thomas Blakey | $138 | $137.42 | +4.9% | May 22, 2026 |
| Argus Research | Analyst unavailable | $190 | $135.91 | +44.5% | May 6, 2026 |
| D.A. Davidson | Analyst unavailable | $165 | $137.31 | +25.4% | May 5, 2026 |
| HSBC | Analyst unavailable | $151 | $144.07 | +14.8% | May 1, 2026 |
| Oppenheimer | Param Singh | $200 | $137.97 | +52.1% | Apr 30, 2026 |
| Mizuho Securities | Gregg Moskowitz | $185 | $132.37 | +40.7% | Apr 14, 2026 |
| Daiwa | Analyst unavailable | $180 | $142.91 | +36.9% | Feb 10, 2026 |
| Deutsche Bank | Brad Zelnick | $200 | $155.6 | +52.1% | Feb 3, 2026 |
| HSBC | Analyst unavailable | $205 | $156.07 | +55.9% | Feb 3, 2026 |
| D.A. Davidson | Analyst unavailable | $180 | $154.46 | +36.9% | Feb 3, 2026 |
| Northland Securities | Analyst unavailable | $190 | $147.76 | +44.5% | Feb 3, 2026 |
| UBS | Analyst unavailable | $180 | $147.76 | +36.9% | Feb 3, 2026 |
| Mizuho Securities | Analyst unavailable | $195 | $147.76 | +48.3% | Feb 3, 2026 |
| Piper Sandler | Analyst unavailable | $230 | $147.76 | +74.9% | Feb 3, 2026 |
| Jefferies | Analyst unavailable | $208 | $165.33 | +58.1% | Jan 22, 2026 |
| Truist Financial | Analyst unavailable | $223 | $174.04 | +69.5% | Jan 6, 2026 |
| Cantor Fitzgerald | Thomas Blakey | $198 | $192.26 | +50.5% | Nov 4, 2025 |
| D.A. Davidson | Analyst unavailable | $215 | $192.67 | +63.5% | Nov 4, 2025 |
| Morgan Stanley | Analyst unavailable | $205 | $192.29 | +55.9% | Nov 4, 2025 |
| Goldman Sachs | Analyst unavailable | $188 | $192.06 | +42.9% | Nov 4, 2025 |
| UBS | Karl Keirstead | $205 | $207.18 | +55.9% | Nov 4, 2025 |
| Robert W. Baird | William Power | $200 | $207.18 | +52.1% | Nov 4, 2025 |
| Mizuho Securities | Gregg Moskowitz | $205 | $207.18 | +55.9% | Nov 4, 2025 |
| Piper Sandler | Analyst unavailable | $201 | $177.21 | +52.8% | Oct 14, 2025 |
| Mizuho Securities | Analyst unavailable | $165 | $171.43 | +25.4% | Sep 15, 2025 |
| Wedbush | Daniel Ives | $200 | $173.27 | +52.1% | Aug 5, 2025 |
| Morgan Stanley | Analyst unavailable | $155 | $173.27 | +17.8% | Aug 5, 2025 |
| Piper Sandler | Brent Bracelin | $182 | $173.27 | +38.4% | Aug 5, 2025 |
| D.A. Davidson | Gil Luria | $170 | $173.27 | +29.2% | Aug 5, 2025 |
| Loop Capital Markets | Analyst unavailable | $180 | $173.27 | +36.9% | Aug 5, 2025 |
| UBS | Analyst unavailable | $165 | $173.27 | +25.4% | Aug 5, 2025 |
| Deutsche Bank | Brad Zelnick | $160 | $173.27 | +21.6% | Aug 5, 2025 |
| Wedbush | Daniel Ives | $160 | $142.5 | +21.6% | Jul 10, 2025 |
| Loop Capital Markets | Mark Schappel | $155 | $135.19 | +17.8% | Jun 12, 2025 |
| Mizuho Securities | Matthew Broome | $94 | $108.86 | -28.5% | May 6, 2025 |
| D.A. Davidson | Gil Luria | $115 | $108.86 | -12.6% | May 6, 2025 |
| Loop Capital Markets | Mark Schappel | $130 | $108.86 | -1.2% | May 6, 2025 |
| Wedbush | Daniel Ives | $140 | $106.38 | +6.4% | May 6, 2025 |
| William Blair | Analyst unavailable | $84 | $90.13 | -36.1% | Mar 5, 2025 |
| D.A. Davidson | Gil Luria | $105 | $103.83 | -20.2% | Feb 4, 2025 |
| Mizuho Securities | Gregg Moskowitz | $80 | $103.83 | -39.2% | Feb 4, 2025 |
| Morgan Stanley | Sanjit Singh | $95 | $103.83 | -27.8% | Feb 4, 2025 |
| Jefferies | Brent Thill | $60 | $103.83 | -54.4% | Feb 4, 2025 |
| Wedbush | Dan Ives | $75 | $64.35 | -43.0% | Nov 25, 2024 |
| Wedbush | Dan Ives | $57 | $51.02 | -56.7% | Nov 5, 2024 |
| D.A. Davidson | Gil Luria | $47 | $51.02 | -64.3% | Nov 5, 2024 |
| Wedbush | Daniel Ives | $45 | $37.12 | -65.8% | Sep 26, 2024 |
| Bank of America Securities | Mariana Perez Mora | $50 | $35.88 | -62.0% | Sep 16, 2024 |
| Northland Securities | Michael Latimore | $35 | $32.59 | -73.4% | Aug 22, 2024 |
| Citigroup | Tyler Radke | $30 | $29.28 | -77.2% | Aug 8, 2024 |
| Goldman Sachs | Gabriela Borges | $16 | $26.59 | -87.8% | Aug 6, 2024 |
| Bank of America Securities | Mariana Perez Mora | $30 | $26.92 | -77.2% | Aug 6, 2024 |
| Wedbush | Dan Ives | $38 | $26.82 | -71.1% | Aug 6, 2024 |
| D.A. Davidson | Gil Luria | $28 | $24.09 | -78.7% | Aug 6, 2024 |
| Wedbush | Daniel Ives | $50 | $28.9 | -62.0% | Jul 18, 2024 |
| Argus Research | Joseph Bonner | $29 | $23.57 | -78.0% | Jun 17, 2024 |
| Mizuho Securities | Gregg Moskowitz | $21 | $21.6 | -84.0% | May 7, 2024 |
| D.A. Davidson | Gil Luria | $24 | $21.7 | -81.8% | May 7, 2024 |
| Deutsche Bank | Brad Zelnick | $20 | $25.21 | -84.8% | May 7, 2024 |
| Wedbush | Dan Ives | $35 | $23.33 | -73.4% | May 6, 2024 |
| Jefferies | Brent Thill | $22 | $21.87 | -83.3% | Feb 6, 2024 |
| Goldman Sachs | Gabriela Borges | $11 | $16.66 | -91.6% | Aug 8, 2023 |
| Wedbush | Daniel Ives | $25 | $16.92 | -81.0% | Jul 28, 2023 |
| Goldman Sachs | Gabriela Borges | $8 | $8.59 | -93.9% | Feb 14, 2023 |
| Jefferies | Analyst unavailable | $7.5 | $6.36 | -94.3% | Jan 5, 2023 |
| Wolfe Research | Alex Zukin | $4.5 | $6.31 | -96.6% | Dec 21, 2022 |
| Citigroup | Analyst unavailable | $5 | $7.64 | -96.2% | Nov 11, 2022 |
| Citigroup | Analyst unavailable | $6 | $9.82 | -95.4% | Aug 9, 2022 |
| Jefferies | Analyst unavailable | $12 | $9.82 | -90.9% | Aug 9, 2022 |
| Deutsche Bank | Brad Zelnick | $8 | $9.82 | -93.9% | Aug 9, 2022 |
| Raymond James | Brian Gesuale | $20 | $10.46 | -84.8% | Jul 21, 2022 |
| Goldman Sachs | Gabriela Borges | $10 | $9.01 | -92.4% | Jun 23, 2022 |
| Bank of America Securities | Mariana Perez Mora | $13 | $8.86 | -90.1% | Jun 21, 2022 |
| Deutsche Bank | Brad Zelnick | $11 | $8.34 | -91.6% | May 15, 2022 |
| Morgan Stanley | Keith Weiss | $13 | $7.46 | -90.1% | May 10, 2022 |
| RBC Capital | Rishi Jaluria | $6 | $7.26 | -95.4% | May 10, 2022 |
| Piper Sandler | Weston Twigg | $14 | $7.46 | -89.4% | May 9, 2022 |
| Piper Sandler | Weston Twigg | $16 | $11.12 | -87.8% | Apr 27, 2022 |
| RBC Capital | Rishi Jaluria | $12 | $11.96 | -90.9% | Apr 25, 2022 |
| Monness | Brian White | $20 | $12.42 | -84.8% | Apr 14, 2022 |
| Piper Sandler | Weston Twigg | $15 | $11.87 | -88.6% | Mar 10, 2022 |
| Morgan Stanley | Keith Weiss | $16 | $11.11 | -87.8% | Mar 7, 2022 |
| Deutsche Bank | Brad Zelnick | $15 | $11.02 | -88.6% | Feb 20, 2022 |
| Wolfe Research | Alex Zukin | $9 | $11.02 | -93.2% | Feb 18, 2022 |
| RBC Capital | Rishi Jaluria | $9 | $11.77 | -93.2% | Feb 17, 2022 |
| Jefferies | Brent Thill | $21 | $12.94 | -84.0% | Feb 4, 2022 |
Track every rating change on PLTR the moment it posts. Free to start.
Start freeMarket reaction
event-close to next-session close
Stock move
-6.9%
Event window
SPY move
+0.8%
Same window
Abnormal move
-7.7%
Stock minus SPY
Volume
1.8×
Versus trailing sessions
Subsequent drift
+4.6%
Up to 20 sessions
PLTRSPY benchmark
Follow PLTR with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeTranscript intelligence
What changed
Revenue growth accelerated from 70% YoY in Q4 FY2025 to 85% YoY in Q1 FY2026, with U.S. revenue surging 104% YoY — the first time U.S. growth exceeded 100%. Net dollar retention climbed from 139% to 150%. The Rule of 40 score rose from 127 to 145, the highest in the company's history. Management raised full-year FY2026 revenue guidance from $7.19 billion to $7.65–$7.662 billion, increasing the implied growth rate from 61% to 71% YoY. Cash from operations reached $899 million. A USDA contract of up to $300 million for agriculture security and supply-chain resilience was a notable new win. Management described AI models identifying thousands of zero-day vulnerabilities as a 'Sputnik moment' in the AI arms race.
Guidance delta
Management raised FY2026 revenue guidance from $7.19 billion to $7.65–$7.662 billion, increasing the implied growth rate from 61% to 71% YoY. U.S. commercial revenue target for FY2026 was set above $3.224 billion. Guidance sentiment remains raised. Management plans to continue investing in technical hiring and product development while maintaining GAAP profitability.
Key takeaways
- Revenue grew 85% YoY to $1.63 billion, beating consensus by 5.9%; EPS of $0.33 beat by 19%.
- U.S. revenue surged 104% YoY, the first time exceeding 100% growth.
- Rule of 40 score climbed to 145, the highest ever for the company.
- Net dollar retention reached 150%, up from 139% in the prior quarter.
- FY2026 revenue guidance raised to $7.65–$7.662 billion, implying 71% YoY growth.
- AIP platform wins spanned government (USDA $300M, Maven, Navy Ship OS) and commercial (GE Aerospace, Motor, Freedom Mortgage).
Management priorities
- Scale AIP adoption across U.S. commercial and government customers.
- Launch next-generation Apollo platform for autonomous cyber-vulnerability remediation.
- Target U.S. commercial revenue above $3.224 billion for FY2026.
- Invest in technical hiring and product pipeline while maintaining GAAP profitability.
- Prioritize U.S. national-security customers and deepen defense partnerships.
Related earnings events
TechnologyINTC · FY2026 Q2 · Calendar Q3 2026Intel Beats on AI Strength, but Foundry Losses and Rising Capex Drag SharesIBM · FY2026 Q2 · Calendar Q3 2026IBM Q2 2026: Revenue Growth Cools to 1% as CapEx Deal Timing Masks Underlying StrengthTXN · FY2026 Q2 · Calendar Q3 2026TXN Q2 2026: Revenue and EPS Beat, Pricing Hikes Begin, Guidance Reaffirmed
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-07-28T10:21:13.366650+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-28T10:21:13.363646+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.